Microbiology data for patients with available cultures from organ space infections (OSI) (n=59 out of 77), according to whether they received empiric antifungals (AF) or not
| Total (n=59) | Empiric AF (n=27) | No empiric AF (n=32) | P value | |
| No growth | 27.1% (16/59) | 25.9% (7/27) | 28.1% (9/32) | |
| Candida spp | 44.1% (26/59) | 48.1% (13/27) | 40.6% (13/32) | 0.532 |
| In isolation | 32.2% (19/59) | 44.4% (12/27) | 21.9% (7/32) | |
| Enterobacter/Klebsiella | 10.2% (6/59) | 7.4% (2/27) | 12.5% (4/32) | |
| Pseudomonas | 1.7% (1/59) | 3.7% (1/27) | 0.0% (0/32) | |
| Streptococci | 5.1% (3/59) | 3.7% (1/27) | 6.3% (2/32) | |
| Stenotrophomonas | 1.7% (1/59) | 3.7% (1/27) | 0.0% (0/32) | |
| Polymicrobial | 18.6% (11/59) | 11.1% (3/27) | 25.0% (8/32) | |
| Included Candida spp | 11.9% (7/59) | 3.7% (1/27) | 18.9% (6/32) |
P values were obtained from a χ2 test.